From: Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C
Number of patients
Duration of treatment
< 1 year
>1 year
Treatment-related mortality
-
Hepatocarcinoma
1
Hepato-renal syndrome
Esophagic varices bleeding
Heart attack
Percent of enrolled patients death
0%
9%